Biological Mechanisms of Action
Antioxidant protection:
Astaxanthin is a potent antioxidant carotenoid whose free radical scavenging ability far exceeds that of many known antioxidants (some measurements show it to be more than 100 times greater than the lipid peroxidation-inhibiting effect of tocopherol (Vitamin E)). Due to its unique molecular structure, it incorporates into cell membranes, spanning the lipid bilayer, thus simultaneously protecting both the surface and the interior of the membrane from the damaging effects of free radicals. As a result, it effectively reduces lipid peroxidation (oxidative damage to fats) in cell membranes. Astaxanthin not only directly neutralizes reactive oxygen and nitrogen species but also activates the cell's own antioxidant defense system: it stimulates the Nrf2 transcription factor, which increases the production of numerous antioxidant enzymes (e.g., superoxide dismutase, catalase, glutathione synthetase). This reduces oxidative stress in the body, which is one of the main drivers of aging. In laboratory studies, the antioxidant activity of astaxanthin outperformed that of other well-known molecules by several orders of magnitude (e.g., it is approximately 550 times more potent as a free radical scavenger than vitamin E, and 6000 times more effective than vitamin C). This outstanding antioxidant protection extends throughout the entire body, including the brain – astaxanthin also crosses the blood-brain barrier, thus exerting its protective effect in the central nervous system.
Anti-inflammatory effect:
Astaxanthin possesses powerful anti-inflammatory properties. It inhibits the NF-κB pathway, which plays a key role in chronic inflammation, and the production of pro-inflammatory cytokines. In animal studies of inflammatory models, its effect in some cases rivaled that of prednisolone (showing efficacy equivalent to a steroid anti-inflammatory drug), but without side effects. Human studies also confirm the anti-inflammatory potential of astaxanthin: in a 2025 clinical trial where patients with community-acquired pneumonia received 12 mg of astaxanthin daily, the levels of inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), significantly decreased compared to placebo. In the same study, the clinical condition of the patients also improved (better organ function scores, a tendency towards shorter recovery time), supporting the immunomodulatory and anti-inflammatory effects of astaxanthin. Further research suggests that 8 mg of astaxanthin daily significantly increased the activity of natural killer cells (NK cells) and interferon-γ production in the human body, while also reducing the level of inflammatory C-reactive protein. This indicates that astaxanthin may help counteract chronic inflammation associated with aging (the phenomenon known as inflammaging) by simultaneously reducing the levels of inflammatory mediators and improving the immune system's response.
